AUTHORS: Firth, Paul G. MBChB, BA et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1608-1616 BACKGROUND: The health care systems of low-income countries have severely limited capacity to treat surgical diseases and conditions. There is limited information about which hospital mortality outcomes are suitable metrics in these settings. METHODS: […]
Read MoreAUTHORS: Bravo, Mauro MD et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1532-1539 BACKGROUND: Acetaminophen is commonly used as part of multimodal analgesia for acute pain. The intravenous formulation offers a more predictable bioavailability compared to oral and rectal acetaminophen. There have been reports of hypotension with intravenous acetaminophen […]
Read MoreAUTHORS: Czarnetzki, Christoph MD, MBA et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1540-1549 BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an alternative to succinylcholine for RSI but recovery times are nearly doubled […]
Read MoreAUTHORS: Reed, Sydney E. MD et al Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1550-1558 BACKGROUND: Optimizing analgesia after cesarean delivery is a priority and requires balancing adequate pain relief with the risk of analgesics-associated adverse effects. Current recommendations are for use of a multimodal, opioid-sparing analgesic regimen that includes […]
Read MoreAUTHORS: Bash, Lori D. PhD, MPH et a; Anesthesia & Analgesia: December 2021 – Volume 133 – Issue 6 – p 1437-1450 BACKGROUND: Neuromuscular blockade (NMB) is a critical part of many surgical procedures. Data on practice patterns of NMB agents (NMBAs) and NMB reversal in recent years in the US ambulatory surgical care setting are […]
Read More